Tower Research Capital LLC (TRC) - FENNEC PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,040
+99.7%
1,470
+134.8%
0.00%
Q2 2023$5,527
+21157.7%
626
-79.9%
0.00%
-100.0%
Q1 2023$26
-10.3%
3,118
+0.8%
0.00%0.0%
Q4 2022$29
-99.9%
3,092
-14.4%
0.00%
Q3 2022$29,000
+26.1%
3,611
-9.2%
0.00%
-100.0%
Q2 2022$23,000
+2200.0%
3,977
+2781.9%
0.00%
Q1 2022$1,000
-96.2%
138
-97.7%
0.00%
Q4 2021$26,000
-16.1%
5,970
+17.6%
0.00%
-100.0%
Q1 2021$31,000
-13.9%
5,075
+4.2%
0.00%0.0%
Q4 2020$36,000
-71.4%
4,870
-76.6%
0.00%0.0%
Q3 2020$126,000
+1160.0%
20,807
+1669.3%
0.00%
Q2 2020$10,000
+42.9%
1,176
+1.1%
0.00%
-100.0%
Q4 2019$7,000
+250.0%
1,163
+183.7%
0.00%
Q3 2019$2,000
-88.2%
410
-88.3%
0.00%
-100.0%
Q1 2019$17,000
+466.7%
3,512
+1029.3%
0.00%
Q3 2018$3,000
+200.0%
311
+279.3%
0.00%
Q1 2018$1,000
-92.9%
82
-92.5%
0.00%
-100.0%
Q4 2017$14,000
+250.0%
1,091
+172.8%
0.00%
Q3 2017$4,0004000.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Solas Capital Management, LLC 849,979$3,400,0003.47%
Southpoint Capital Advisors LP 3,997,214$15,989,0000.60%
Opaleye Management Inc. 295,000$1,180,0000.36%
683 Capital Management, LLC 971,351$3,885,0000.35%
Avoro Capital Advisors LLC 1,105,999$4,424,0000.15%
Eventide Asset Management 720,000$2,880,0000.09%
Granahan Investment Management 439,083$1,756,0000.09%
Hartford Financial Management Inc. 20,300$81,0000.03%
OXFORD ASSET MANAGEMENT LLP 75,236$301,0000.01%
Paloma Partners Management Co 54,400$218,0000.00%
View complete list of FENNEC PHARMACEUTICALS INC shareholders